[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"condition:lewy-body-dementia":3},{"name":4,"total":5,"recruiting":6,"trials":7,"biomarkers":241,"states":242},"Lewy Body Dementia",38,26,[8,16,23,29,35,41,47,53,60,67,73,79,85,91,97,103,109,115,121,127,133,139,146,152,159,165,171,178,183,189,195,201,207,213,218,224,230,235],{"nct_id":9,"title":10,"phases":11,"status":13,"updated_at":14,"content_modified":15},"NCT07029581","Phase 2, Efficacy and Safety Study of ACP-204 in Lewy Body Dementia Psychosis",[12],"Phase 2","RECRUITING","2026-08-26T02:18:49.989941Z","2026-05-05T02:43:28.901564Z",{"nct_id":17,"title":18,"phases":19,"status":13,"updated_at":21,"content_modified":22},"NCT05590637","Comparing Antipsychotic Medications in LBD Over Time",[20],"Phase 4","2026-08-26T02:18:39.640967Z","2026-05-05T02:43:28.647537Z",{"nct_id":24,"title":25,"phases":26,"status":13,"updated_at":27,"content_modified":28},"NCT07589595","A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7)",[12],"2026-08-26T02:18:06.247899Z","2026-05-29T15:36:40.200991Z",{"nct_id":30,"title":31,"phases":32,"status":13,"updated_at":33,"content_modified":34},"NCT06862557","Pulsed Electromagnetic Field Treatment With Dementia Patients",[],"2026-08-26T02:17:09.131534Z","2026-05-05T02:43:27.732106Z",{"nct_id":36,"title":37,"phases":38,"status":13,"updated_at":39,"content_modified":40},"NCT07137949","Delirium in Neurodegenerative Disease Patients: A Music Therapy Intervention for Hospital Care",[],"2026-08-26T02:16:52.995882Z","2026-05-05T02:43:27.810275Z",{"nct_id":42,"title":43,"phases":44,"status":13,"updated_at":45,"content_modified":46},"NCT02795052","Neurologic Stem Cell Treatment Study",[],"2026-08-26T02:15:11.740957Z","2026-04-29T02:57:57.086071Z",{"nct_id":48,"title":49,"phases":50,"status":13,"updated_at":51,"content_modified":52},"NCT07176286","18F-mFBG Cardiac Uptake With Lewy Body Dementia",[12],"2026-08-26T02:19:29.922117Z","2026-05-05T02:43:27.324273Z",{"nct_id":54,"title":55,"phases":56,"status":13,"updated_at":58,"content_modified":59},"NCT03143374","PET Tau - Neurodegenerative Disease Imaging",[57],"Phase 2\u002FPhase 3","2026-08-26T02:16:03.788292Z","2026-05-05T02:43:28.343973Z",{"nct_id":61,"title":62,"phases":63,"status":13,"updated_at":65,"content_modified":66},"NCT07693140","Low-Dose Radiotherapy for Alzheimer's Disease",[64],"Phase 1\u002FPhase 2","2026-08-26T02:16:49.565137Z","2026-07-19T19:36:05.157476Z",{"nct_id":68,"title":69,"phases":70,"status":13,"updated_at":71,"content_modified":72},"NCT06057909","A Study of Neurodegeneration and Neuronal Fluctuations in Lewy Body Disease and Alzheimer's Disease",[],"2026-08-26T02:16:44.178623Z","2026-05-13T02:55:06.404624Z",{"nct_id":74,"title":75,"phases":76,"status":13,"updated_at":77,"content_modified":78},"NCT05347407","Parkinson's Disease Biomarkers in Nerve Cells in the Gut",[],"2026-08-26T02:17:59.904383Z","2026-05-13T02:55:06.301139Z",{"nct_id":80,"title":81,"phases":82,"status":13,"updated_at":83,"content_modified":84},"NCT04997642","Parkinson's Disease and Movement Disorders Clinical Database",[],"2026-08-26T02:17:52.450442Z","2026-05-13T02:55:06.278551Z",{"nct_id":86,"title":87,"phases":88,"status":13,"updated_at":89,"content_modified":90},"NCT05010603","Late Onset Alzheimer's Disease",[],"2026-08-26T02:16:16.995720Z","2026-05-13T02:55:06.277781Z",{"nct_id":92,"title":93,"phases":94,"status":13,"updated_at":95,"content_modified":96},"NCT03019757","Distinguishing Between Alzheimer's Disease, Lewy Body Dementia, and Parkinson's Disease",[],"2026-08-26T02:15:01.639696Z","2026-05-13T02:55:06.105613Z",{"nct_id":98,"title":99,"phases":100,"status":13,"updated_at":101,"content_modified":102},"NCT06203106","NYSCF Scientific Discovery Biobank",[],"2026-08-26T02:15:57.572488Z","2026-05-13T02:55:06.425562Z",{"nct_id":104,"title":105,"phases":106,"status":13,"updated_at":107,"content_modified":108},"NCT04715399","UPenn Observational Research Repository on Neurodegenerative Disease",[],"2026-08-26T02:18:00.873391Z","2026-05-13T02:55:06.266233Z",{"nct_id":110,"title":111,"phases":112,"status":13,"updated_at":113,"content_modified":114},"NCT03702907","DC Longitudinal Study on Aging and Specimen Bank",[],"2026-08-26T02:19:29.119921Z","2026-05-13T02:55:06.175337Z",{"nct_id":116,"title":117,"phases":118,"status":13,"updated_at":119,"content_modified":120},"NCT03233646","Retinal Imaging in Neurodegenerative Disease",[],"2026-08-26T02:19:27.519777Z","2026-05-13T02:55:06.120078Z",{"nct_id":122,"title":123,"phases":124,"status":13,"updated_at":125,"content_modified":126},"NCT02194816","Modifiable Variables in Parkinsonism (MVP)",[],"2026-08-26T02:17:05.997056Z","2026-05-13T02:55:06.083137Z",{"nct_id":128,"title":129,"phases":130,"status":13,"updated_at":131,"content_modified":132},"NCT01799915","Natural History Study of Synucleinopathies",[],"2026-08-26T02:19:14.560989Z","2026-05-13T02:55:06.077141Z",{"nct_id":134,"title":135,"phases":136,"status":13,"updated_at":137,"content_modified":138},"NCT05014971","Telehealth in Lewy Body Dementia",[],"2026-08-03T02:41:35.511782Z","2026-05-05T02:43:29.507857Z",{"nct_id":140,"title":141,"phases":142,"status":13,"updated_at":144,"content_modified":145},"NCT06098612","PET Imaging Evaluation of [11C]SY08",[143],"Early Phase 1","2026-08-26T02:15:22.311223Z","2026-05-05T02:43:29.296692Z",{"nct_id":147,"title":148,"phases":149,"status":13,"updated_at":150,"content_modified":151},"NCT06467461","Identification of Prodromal Neurodegeneration in Serotonergic-Induced REM Sleep Behavior Disorder",[],"2026-08-03T03:38:39.261584Z","2026-05-05T02:43:28.509363Z",{"nct_id":153,"title":154,"phases":155,"status":13,"updated_at":157,"content_modified":158},"NCT04246437","[18F]F-DOPA Imaging in Patients With Autonomic Failure",[156],"Phase 1","2026-08-26T02:18:53.782384Z","2026-05-05T02:43:28.214049Z",{"nct_id":160,"title":161,"phases":162,"status":13,"updated_at":163,"content_modified":164},"NCT05357612","Characterization of the Serotonin 2A Receptor Selective PET Tracer [18F]MH.MZ in Patients With Neurodegenerative Diseases",[20],"2026-08-26T02:18:17.007929Z","2026-05-05T02:43:27.661695Z",{"nct_id":166,"title":167,"phases":168,"status":13,"updated_at":169,"content_modified":170},"NCT07284290","Elucidating the Role of Cholinergic Degeneration in Cognitive Fluctuations in Lewy Body Dementia",[20],"2026-08-26T02:15:41.377360Z","2026-05-05T02:35:31.701867Z",{"nct_id":172,"title":173,"phases":174,"status":175,"updated_at":176,"content_modified":177},"NCT04760860","Terazosin for Dementia With Lewy Bodies",[64],"NOT_YET_RECRUITING","2026-08-26T02:17:46.653867Z","2026-05-05T02:43:28.660077Z",{"nct_id":179,"title":180,"phases":181,"status":175,"updated_at":131,"content_modified":182},"NCT07718906","Neuromodulation for Behavioral Changes in Neurological Disorders",[],"2026-07-24T01:27:14.917911Z",{"nct_id":184,"title":185,"phases":186,"status":175,"updated_at":187,"content_modified":188},"NCT07637097","VOCALE LBD: Online Peer Support for Caregivers of People With Lewy Body Dementia",[],"2026-08-26T02:19:01.741747Z","2026-06-14T18:39:22.255000Z",{"nct_id":190,"title":191,"phases":192,"status":175,"updated_at":193,"content_modified":194},"NCT07240805","Digital Health Technologies for Progressive Supranuclear Palsy and Dementia With Lewy Bodies",[],"2026-08-26T02:15:42.447052Z","2026-05-13T02:55:06.680076Z",{"nct_id":196,"title":197,"phases":198,"status":175,"updated_at":199,"content_modified":200},"NCT07646652","Alpha-synuclein Education and Disclosure in Individuals With Preclinical and Symptomatic Lewy Body Disease",[],"2026-08-26T02:16:47.762107Z","2026-06-16T05:54:07.903276Z",{"nct_id":202,"title":203,"phases":204,"status":205,"updated_at":119,"content_modified":206},"NCT04786223","Targeting Neuroinflammation as a Contributing Pathology in Alzheimer's Disease Dementia and Related Dementias",[12],"ENROLLING_BY_INVITATION","2026-07-05T18:42:10.712531Z",{"nct_id":208,"title":209,"phases":210,"status":205,"updated_at":211,"content_modified":212},"NCT03582488","Longitudinal Imaging Biomarkers of Disease Progression in DLB",[20],"2026-08-26T02:17:14.343713Z","2026-06-16T05:54:07.967236Z",{"nct_id":214,"title":215,"phases":216,"status":205,"updated_at":144,"content_modified":217},"NCT05514106","MIBG in Aging and Neurologic Disorders",[20],"2026-06-16T05:54:08.079315Z",{"nct_id":219,"title":220,"phases":221,"status":205,"updated_at":222,"content_modified":223},"NCT01453127","DaTSCAN Imaging in Aging and Neurodegenerative Disease",[20],"2026-08-26T02:18:43.501109Z","2026-06-16T05:54:07.946347Z",{"nct_id":225,"title":226,"phases":227,"status":205,"updated_at":228,"content_modified":229},"NCT00950430","Imaging of Brain Amyloid Plaques in the Aging Population",[20],"2026-08-26T02:16:48.735701Z","2026-06-16T05:54:07.944556Z",{"nct_id":231,"title":232,"phases":233,"status":205,"updated_at":169,"content_modified":234},"NCT06984757","Mid-frontal Delta\u002FTheta and Cognitive Control",[],"2026-06-16T05:54:07.849245Z",{"nct_id":236,"title":237,"phases":238,"status":205,"updated_at":239,"content_modified":240},"NCT05826457","North American Prodromal Synucleinopathy Consortium Stage 2",[],"2026-08-26T02:17:57.997171Z","2026-05-13T02:55:06.379597Z",[],[243,247,251,255,258,262,265,268,272,276,279,282,285],{"state":244,"count":245,"slug":246},"Minnesota",10,"minnesota",{"state":248,"count":249,"slug":250},"Florida",8,"florida",{"state":252,"count":253,"slug":254},"Massachusetts",6,"massachusetts",{"state":256,"count":253,"slug":257},"Pennsylvania","pennsylvania",{"state":259,"count":260,"slug":261},"New York",5,"new-york",{"state":263,"count":260,"slug":264},"Texas","texas",{"state":266,"count":260,"slug":267},"Washington","washington",{"state":269,"count":270,"slug":271},"California",4,"california",{"state":273,"count":274,"slug":275},"District of Columbia",3,"district-of-columbia",{"state":277,"count":274,"slug":278},"Missouri","missouri",{"state":280,"count":274,"slug":281},"North Carolina","north-carolina",{"state":283,"count":274,"slug":284},"Tennessee","tennessee",{"state":286,"count":274,"slug":287},"Virginia","virginia"]